Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Patient case

A long-standing severe psoriasis plaque

    • Cases
    • Dermatology and venereology
    • RX
  • 1 minute read

In the following video, Dr. Basile Darbellay presents the case of a 40-year-old patient who has suffered from severe psoriasis for 25 years. Based on the patient’s history and clinical condition, the use of new treatment options are discussed. How would you treat the patient? Please vote for the option you prefer and leave your comment on this case!

This clinical case presentation was selected by Dr. med. Basile Darbellay, MD, MD-PhD, on behalf of AbbVie Switzerland and is for illustration purposes only. For robust data regarding the efficacy and safety of risankizumab, we refer to the clinical studies and current professional information for SKYRIZI® [1].

http://www.123formbuilder.com/form-5666671/form

1. SKYRIZI® product information on www.swissmedicinfo.ch. Information status: March 2020

Professional Information SKYRIZI® (Risankizumab):

This article was produced with the financial support of AbbVie AG, Switzerland.

CH-SKZD-200077_10/2020

Autoren
  • Dr. sc. nat. Jennifer Keim
Previous Article
  • INOCA phenomenon and co.

Late-Breaking News Highlights

  • Cardiology
  • Congress Reports
  • RX
View Post
Next Article
  • Type 2 diabetes mellitus

Heart and kidney protected in different patient groups

  • Endocrinology and Diabetology
  • Partner Content
  • RX
  • Training with partner
View Post
You May Also Like
View Post
  • 12 min
  • SURPASS-CVOT

Tirzepatide versus Dulaglutide in T2D with ASCVD

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Pharmacology and toxicology
    • Studies
View Post
  • 6 min
  • Secondary prevention after ACS: individually optimized lipid management

Trend towards early combination therapy and new strategies for lowering Lp(a)

    • RX
    • Cardiology
    • Congress Reports
    • General Internal Medicine
    • Studies
View Post
  • 27 min
  • Pediatric Brain Tumors

Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls

    • RX
    • CME continuing education
    • Neurology
    • Oncology
    • Pediatrics
    • Psychiatry and psychotherapy
    • Studies
View Post
  • 13 min
  • What the latest studies on the entire EF spectrum mean for clinical practice

Heart Failure – The 2026 Evidence Update

    • RX
    • Cardiology
    • Education
    • Endocrinology and Diabetology
    • Studies
View Post
  • 5 min
  • Acute ischemic stroke

Alteplase and Tenecteplase Are on the Same Level

    • RX
    • Education
    • Emergency and intensive care medicine
    • Neurology
    • Pharmacology and toxicology
    • Studies
View Post
  • 5 min
  • CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment

SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes

    • RX
    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nephrology
    • Studies
View Post
  • 2 min
  • Wearables: screening via smartwatch?

New study on atrial fibrillation in high-risk patients

    • RX
    • Cardiology
    • Practice Management
    • Prevention and health care
    • Studies
View Post
  • 13 min
  • Planning a Family, Pregnancy, and Breastfeeding

Update on Anti-Rheumatic Medications

    • RX
    • CME continuing education
    • General Internal Medicine
    • Gynecology
    • Pharmacology and toxicology
    • Rheumatology
    • Studies
Landingpage Fachinfo Landingpage Button
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Update on Anti-Rheumatic Medications
  • 2
    Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
  • 3
    Focus on preventive care options
  • 4
    Inflammation as a Treatment Goal in Its Own Right
  • 5
    Personalized Treatment Before a Planned Pregnancy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.